| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/09/2011 | CN101228957B Method of preparing low molecular active substance pill of holothurian and oyster |
| 02/09/2011 | CN101204466B Novel antidiabetic |
| 02/09/2011 | CN101190253B Medicinal composition containing mongolian snakegourd and notoginseng |
| 02/09/2011 | CN101176770B Pharmaceutical composition of folium ginkgo and cattail pollen |
| 02/09/2011 | CN101117349B A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof |
| 02/09/2011 | CN101084880B Biological solid dispersion of vitamin E esters derivatives and preparation method thereof |
| 02/09/2011 | CN101073596B Alpha-glycosidase inhibitor, its extraction and use |
| 02/09/2011 | CN101010080B Remedy for hyperlipemia |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/08/2011 | US7884080 Administering an azetidinone compound for treating a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease; T-type calcium channel blocking agent, an antagonist of TRPV1, an agonist of TRPV1, of GPR119, antagonist of NPCL1 |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/08/2011 | CA2602781C 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase |
| 02/08/2011 | CA2562951C Indene derivatives and process for the preparation thereof |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2484450C Ligands that are inhibitors of the rar receptors |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/03/2011 | WO2011014766A2 Crystallization method and bioavailability |
| 02/03/2011 | WO2011014707A2 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | WO2011014661A2 Liver x receptor agonists |
| 02/03/2011 | WO2011014261A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | WO2011013999A2 Composition containing chitooligosaccharide for recovering from fatigue |
| 02/03/2011 | WO2011013987A2 2,2-disubstituted-2h-chromene compound |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013644A1 Substituted piperidine compound |
| 02/03/2011 | WO2011012800A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof |
| 02/03/2011 | WO2011012718A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | WO2011012602A1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis |
| 02/03/2011 | WO2011012592A1 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | WO2011011919A1 Composition for lowering blood glucose |
| 02/03/2011 | WO2011011905A1 A preparation process of blood fat and blood sugar lowering compound preparation |
| 02/03/2011 | WO2011011872A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/03/2011 | WO2010107704A3 Ellipticine compounds for treating obesity |
| 02/03/2011 | WO2010106187A3 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders |
| 02/03/2011 | WO2010092090A3 Novel salts of sitagliptin |
| 02/03/2011 | WO2009158412A8 Sustained delivery of exenatide and other polypeptides |
| 02/03/2011 | US20110030077 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 02/03/2011 | US20110028742 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 02/03/2011 | US20110028554 pharmaceutical compositions comprising diiodothyronine and their therapeutic use |
| 02/03/2011 | US20110028542 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 02/03/2011 | US20110028537 Somatic cell reprogramming |
| 02/03/2011 | US20110028530 Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid 471 |
| 02/03/2011 | US20110028529 Novel crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid 471 |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028520 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/03/2011 | US20110028517 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist |
| 02/03/2011 | US20110028515 New piperidine derivatives |
| 02/03/2011 | US20110028514 Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 02/03/2011 | US20110028512 Bis-heterocyclic imidazolyl compounds |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028505 Compositions and methods for reducing food cravings |
| 02/03/2011 | US20110028501 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/03/2011 | US20110028499 Pharmaceutical combination comprising vitamin k |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028475 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028467 Heterocyclic derivatives |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028462 Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 02/03/2011 | US20110028437 Phosphorylated pyrone analogs and methods |
| 02/03/2011 | US20110028435 Crystallization method and bioavailability |
| 02/03/2011 | US20110028429 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028416 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 02/03/2011 | US20110028414 Glucopyranoside derivatives |
| 02/03/2011 | US20110028392 Methods for use of branched amino acids |
| 02/03/2011 | US20110028391 Use of GLP-1 Peptides |
| 02/03/2011 | US20110028390 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 02/03/2011 | US20110028389 Use of infant formula with reduced protein content |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/03/2011 | US20110027393 Human diabetes susceptibility eefsec gene |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027371 Nanoparticulate statin formulations and novel statin combinations |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027355 High-fluidity and non-caking pulverulent crystalline maltitol composition |
| 02/03/2011 | US20110027348 Composition and method inhibiting inflammation |
| 02/03/2011 | US20110027340 Implantable drug depot for weight control |
| 02/03/2011 | US20110027305 Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus |
| 02/03/2011 | US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027287 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/03/2011 | US20110027241 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
| 02/03/2011 | US20110027192 Slim-fit fat burning water |
| 02/03/2011 | US20110027187 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |